Fluticasone Propionate
Product Images NDC 53002-2310

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 53002-2310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

Chemical structure diagram of fluticasone propionate showing its molecular configuration with various functional groups and bonds represented.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

A line graph comparing the percentage change from baseline in FEV1 over 12 weeks and at an endpoint for two groups: placebo and Fluticasone Propionate HFA 88 mcg twice daily. The graph shows higher improvements in FEV1 for the fluticasone group compared to placebo.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

A line graph showing the percent change from baseline in FEV1 over 12 weeks for placebo and three dosing regimens of Fluticasone Propionate HFA (88 mcg, 220 mcg, and 440 mcg twice daily). The graph plots week on the x-axis and percent change on the y-axis, with distinct markers for each treatment group.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

A bar chart showing the percentage of subjects with 100% reduction in dose and the percentage of subjects with an increase in dose for Placebo, Fluticasone Propionate HFA 440 mcg twice daily, and Fluticasone Propionate HFA 880 mcg twice daily groups. Bars compare these three groups across two categories.*

FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

An illustration showing parts of a Fluticasone Propionate HFA inhaler. It labels the metal canister, dark orange plastic actuator, dark orange mouthpiece with a counter display, and a separate peach-colored cap designed to cover the mouthpiece.*

FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

An instructional illustration showing a person removing the protective cap from a Fluticasone Propionate HFA inhaler by pulling it straight off with one hand while holding the inhaler in the other hand.*

FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

An instructional illustration showing a person using an inhaler spray. The image depicts a hand holding the inhaler, pressing down on the top to release the spray, with an arrow indicating the direction to press, and the spray being emitted.*

FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

An instructional line drawing showing a hand holding a Fluticasone Propionate HFA inhaler. The image illustrates how to properly position the inhaler for use, with the thumb supporting the base and the index finger ready to press the canister.*

FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

An instructional illustration showing the proper mouthpiece-down position for using an inhaler. The image highlights the dark orange mouthpiece and a separate peach-colored cap, with a hand holding the inhaler in the correct orientation for administration.*

FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

An instructional illustration showing a side profile of a person's face exhaling air. Text beside the image reads, "Breathe out as much air as you can," indicating a step in inhaler use or respiratory instructions.*

FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

An instructional illustration showing a person holding an inhaler near their mouth with the instruction 'Push down and breathe in' indicated by an arrow. This depicts the proper technique for using an inhaler device, demonstrating how to place the mouthpiece and inhale medication effectively.*

FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

An instructional illustration showing a person rinsing their mouth by spitting water into a sink, with a glass of water visible nearby. This image is commonly used to demonstrate mouth rinsing after using an inhaler medication such as Fluticasone Propionate HFA.*

FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

An instructional diagram showing two illustrations of a nasal spray device. The top image labeled 'Not blocked' depicts the spray properly dispersing. The bottom image labeled 'Blocked' shows the spray being obstructed, demonstrating correct versus incorrect spray usage.*

FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

An instructional illustration showing how to insert or rotate a small cylindrical component, possibly a vial or cartridge, into a device, with an arrow indicating the direction of rotation.*

FDA Label Image

Label Image (Lbl530022310)

Fluticasone Propionate HFA 110 mcg inhaler carton label from RPK Pharmaceuticals, Inc. The label includes dosing instructions to inhale 2 puffs twice a day or as directed. It features barcodes, placeholders for clinic and patient information, and regulatory and billing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.